Home>Clinical Outcomes>Producing QALY’s: Measuring the impact of self-management of Type 1 and Type 2 Diabetes
Producing QALY’s: Measuring the impact of self-management of Type 1 and Type 2 Diabetes
10th December 2019
HASMID-10 preference-based utility tool now available! Health economists can now build Quality-Adjusted Life Year (QALY) evidence in support of their interventions around the self-management of Type 1 and Type 2 diabetes.
The Health and Self-Management in Diabetes (HASMID-10) Utility measure is a preference-based data analysis tool for extracting valuable health economic data from the existing HASMID-10 Patient Reported Outcomes Measure. Health economists can now build Quality-Adjusted Life Year (QALY) evidence in support of their interventions.
Utility weights are generated from the score results of each dimension within the HASMID-10, being embedded into a short syntax file that is used with the common data analysis package SPSS. Algorithms have also been extended to a universal spreadsheet file, which can also be used.
The HASMID-10 preference-based utility tool was developed by our associates at The University of Sheffield and is now available to licence from the Clinical Outcomes team at Oxford University Innovation.